Professional Documents
Culture Documents
CHS/BSN-CURR -RLEFORM-002d
Revision No. Effective Date Page No.
00 02.24.2023 1 of 1
DRUG STUDY
Brand Name: Buscopan Generic NameHyoscine-N-butylbromide (HnBB) Drug Classification: Antispasmodic; Anticholinergic
Responsibilities in the Nursing Process (ADPIE) Responsibilities in the Nursing Process (ADPIE)
Assessment: Implementation
Obtain baseline vital signs, assess urine output, check medical history, obtain patient’s during drug Determine fluid intake and output and assess bowel sounds
history Examine for constipation caused by decrease in GI motility.
Administer medication as prescribed
Diagnosis Drug compatibility should be monitored closely in patients requiring adjunctive therapy
Impaired urinary elimination related to urinary retention Avoid driving & operating machinery after parenteral administration.
Avoid strict heat
Planning Raise side rails as a precaution because some patients become temporarily excited or disoriented and
Patient will not have side effects that may become a health problem some develop amnesia or become drowsy.
Reorient patient, as needed, Tolerance may develop when therapy is prolonged
Atropine-like toxicity may cause dose related adverse reactions. Individual tolerance varies greatly
Oerdose may cause curare-like effects, such as respiratory paralysis. Keep emergency equipment
available.
Evaluation
Evaluate patient’s response to the anticholinergic
EVALUATION TOOL:
UNACCEPTABLE SATISFACTORY EXCEPTIONAL REMARKS
1-7 8-12 13-20
Only a few of the drugs were listed down; or some drugs were not some drugs were not listed down; intended indication and mechanism Listed down all the drugs; intended indication and
listed down; intended indication and mechanism of action of the of action of the given medication/s as well as the side-effects, mechanism of action of the given medication/s as well as
given medication/s as well as the side-effects, contraindications and contraindications and nursing responsibilities were correct and relevant the side-effects, contraindications and nursing
nursing responsibilities were incorrect and not relevant to the to the assigned patient responsibilities were correct and relevant to the assigned
assigned patient patient
Like all medicines, BUSCOPAN Tablets can cause side effects, although not everybody gets them. The following side effects may happen with this medicine.
Stop taking your medicine and see a doctor straight away if you notice any of the following serious side effects - you may need urgent medical treatment:
• Allergic reactions such as skin reactions e.g. nettle rash, itching (affects fewer than 1 in 100 people), rash, redness of the skin
• Severe allergic reactions (anaphylactic shock) such as difficulty breathing, feeling faint or dizzy (shock)
• Painful red eye with loss of vision
Other side effects
• Dry mouth (affects fewer than 1 in 100 people)
• Abnormal sweating or reduced sweating (affects fewer than 1 in 100 people)
• Increased heart rate (affects fewer than 1 in 100 people)
• Being unable to pass water (urine) (affects fewer than 1 in 1,000 people)
AR:
1. CNS: dizziness, anaphylactic reactions, anaphylactic shock, increased ICP, disorientation, restlessness, irritability, dizziness, drowsiness, headache, confusion, hallucination, delirium, impaired memory
2. CV: hypotension, tachycardia, palpitations, flushing
3. GI: Dry mouth, constipation, nausea, epigastric distress
4. DERM: flushing, dyshidrosis
5. GU: Urinary retention, urinary hesitancy
6. Resp: dyspnea, bronchial plugging, depressed respiration
7. EENT: mydriasis, dilated pupils, blurred vision, photophobia, increased intraocular pressure, difficulty of swallowing.
Active management of labor is a part and parcel of modern obstetrics. There are various mechanical and pharmacological
methods by which the cervical dilatation can be facilitated e.g., sweeping of membranes and stretching of the cervix causes
local release of prostaglandins resulting in reduction in the need for formal induction of labor, amniotomy, cervical application of
relaxin, estradiol and hylase, prostaglandins in various formulations for induction of labor, especially PGE2 gel for cervical
ripening. Oxytocin is proven to induce and augment labor. Buscopan (Hyoscine Butyl-N-Bromide) and Scopolamine have been
used for pain relief and shortening of labor. Epidosin (Valethemate bromide) has neurotropic and musculotropic actions,
resulting in relaxation of cervical musculature leading to quick dilatation of cervix and shortened labor. Drotaverine hydrochloride
shortens duration of the dilatation stage of labor [4]. Anafortan (Camylofin Dihydrochloride) is a selective PDE-4 enzyme
inhibitor which facilitates cervical effacement and dilatation, accelerates labor, regulates the autonomic system and thereby
prevents disordered progress of labor.
It was concluded that Anafortan is a potent and effective drug to shorten the first stage of labor. Its effect on shortening duration
of labor is significantly better than Epidosin + Buscopan group. However both the drugs have almost similar side effects and
have no effect on uterine activity. Both the drugs have no effect on second and third stage of labor as regards to duration or
complications. The difference between the two groups as regards to instrumental delivery was insignificant. Neonatal outcome
was not affected in both the groups.